| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 13397 | 2021 |
| 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer … Eur Heart J 37 (36), 2768-2801, 2016 | 3539 | 2016 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 2082 | 2022 |
| 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 44 (37), 3627-3639, 2023 | 1333 | 2023 |
| Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology PM Seferović, MC Petrie, GS Filippatos, SD Anker, G Rosano, ... European journal of heart failure 20 (5), 853-872, 2018 | 746 | 2018 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 662 | 2020 |
| Insights into onco-cardiology: atrial fibrillation in cancer D Farmakis, J Parissis, G Filippatos Journal of the American College of Cardiology 63 (10), 945-953, 2014 | 424 | 2014 |
| Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology PM Seferović, M Polovina, J Bauersachs, M Arad, T Ben Gal, LH Lund, ... European journal of heart failure 21 (5), 553-576, 2019 | 416 | 2019 |
| Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E uropean A … J Čelutkienė, R Pudil, T López‐Fernández, J Grapsa, P Nihoyannopoulos, ... European journal of heart failure 22 (9), 1504-1524, 2020 | 396 | 2020 |
| Cardiac involvement in thalassemia intermedia: a multicenter study A Aessopos, D Farmakis, M Karagiorga, E Voskaridou, A Loutradi, ... Blood, The Journal of the American Society of Hematology 97 (11), 3411-3416, 2001 | 368 | 2001 |
| Iron overload cardiomyopathy in clinical practice DT Kremastinos, D Farmakis Circulation 124 (20), 2253-2263, 2011 | 357 | 2011 |
| Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association … R Pudil, C Mueller, J Čelutkienė, PA Henriksen, D Lenihan, S Dent, ... European journal of heart failure 22 (11), 1966-1983, 2020 | 320 | 2020 |
| Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia A Aessopos, D Farmakis, S Deftereos, M Tsironi, S Tassiopoulos, ... Chest 127 (5), 1523-1530, 2005 | 307 | 2005 |
| β-thalassemia cardiomyopathy: history, present considerations, and future perspectives DT Kremastinos, D Farmakis, A Aessopos, G Hahalis, E Hamodraka, ... Circulation: Heart Failure 3 (3), 451-458, 2010 | 286 | 2010 |
| Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology GMC Rosano, B Moura, M Metra, M Böhm, J Bauersachs, T Ben Gal, ... European journal of heart failure 23 (6), 872-881, 2021 | 281 | 2021 |
| Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry J Lopez-Sendon, C Alvarez-Ortega, P Zamora Auñon, A Buño Soto, ... European heart journal 41 (18), 1720-1729, 2020 | 276 | 2020 |
| Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure … C Maack, M Lehrke, J Backs, FR Heinzel, JS Hulot, N Marx, WJ Paulus, ... European heart journal 39 (48), 4243-4254, 2018 | 272 | 2018 |
| Acute heart failure: epidemiology, risk factors, and prevention D Farmakis, J Parissis, J Lekakis, G Filippatos Revista Española de Cardiología (English Edition) 68 (3), 245-248, 2015 | 256 | 2015 |
| Cardiac status in well‐treated patients with thalassemia major A Aessopos, D Farmakis, A Hatziliami, C Fragodimitri, F Karabatsos, ... European journal of haematology 73 (5), 359-366, 2004 | 237 | 2004 |
| Intravenous ferric carboxymaltose in iron‐deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR‐HF trial G Filippatos, D Farmakis, JC Colet, K Dickstein, TF Lüscher, ... European journal of heart failure 15 (11), 1267-1276, 2013 | 208 | 2013 |